No Data
No Data
Biotech Bankruptcies Hit a Record Despite Sector's Recovery
COVID-19 Treatment Developer Humanigen Files for Chapter 11 Bankruptcy
COVID Pick Humanigen Files for Bankruptcy
Humanigen Announces First Participant Dosed in RATinG Trial of Lenzilumab for Early Treatment of Acute Graft Versus Host Disease Following Allogeneic Stem Cell Transplantation
The RATinG (Risk Adapted Therapy in Acute GvHD) is the first trial to explore granulocyte-macrophage colony-stimulating factor (GM-CSF) neutralization for the early treatment of participants with high
U.S. Shares Higher at Close of Trade; Dow Jones Industrial Average up 0.08%
Sector Update: Health Care Stocks Steady Tuesday Afternoon
Health care stocks were little changed Tuesday afternoon, with the NYSE Health Care Index fractionally higher and the Health Care Select Sector SPDR Fund (XLV) down nearly 0.1%. The iShares Biotechnol
No Data